Application of Classic Utilities to Published Pediatric Cost-Utility Studies

被引:10
|
作者
Finnell, S. Maria E. [1 ,3 ]
Carroll, Aaron E. [1 ,2 ,3 ]
Downs, Stephen M. [1 ,2 ,3 ]
机构
[1] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
[2] Ctr Hlth Policy & Professionalism Res, Indianapolis, IN USA
[3] Regenstrief Inst Healthcare, Indianapolis, IN USA
关键词
cost effectiveness; cost-utility analysis; quality-adjusted life years; utility; child; cost benefit analysis; INTRATHECAL BACLOFEN THERAPY; QUALITY-OF-LIFE; ROTAVIRUS VACCINATION; CHILDHOOD IMMUNIZATION; THRESHOLD RETINOPATHY; INFANT VACCINATION; CHILDREN; HEALTH; IMPACT; CARE;
D O I
10.1016/j.acap.2011.09.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: Economic analyses, such as cost-utility analyses (CUAs), are dependent on the quality of the data used. Our objective was to test how health utility values (measurements of patient preference) assessed by recommended methods (classic utilities) would impact the conclusions in published pediatric CUAs. METHODS: Classic utilities for pediatric health states were obtained by recommended utility assessment methods, time trade-off, and standard gamble in 4016 parent interviews. To test the impact of these utilities on published studies, we obtained a sample of published pediatric CUAs by searching Medline, EMBASE, EconLit, Health Technology Assessment Database, Cochrane Database on Systematic Reviews, Database of Abstracts of Reviews of Effects, and the Cost Effective Analysis (CEA) Registry at Tufts Medical Center, using search terms for cost-utility analysis. Articles were included when results were presented as cost per quality adjusted life-years (QALYs), the interventions were for children <18 years of age and included at least one of the following health states: attention deficit hyperactivity disorder, asthma, gastroenteritis, hearing loss, mental retardation, otitis media, seizure disorder, or vision loss. Studies that did not include these or equivalent health states were excluded. For each CUA, we determined utilities (values for patient preference), the utility assessment method used, and presence of one-way sensitivity analyses (SAs) on utilities. When one-way SAs were conducted, we determined if using our classic utilities would change the result of the CUA. When an SA was not presented, we determined if using our classic utilities would tend to support or not support the published conclusions. RESULTS: We evaluated 39 articles. Eighteen articles presented results of one-way SAs on utilities. Seven articles presented SAs over a range that included our classic utilities. In 4 of the 7, using classic utilities would change the conclusion of the study. For the 32 articles where no one-way SA were presented (n = 21), or where the classic utilities fell outside the range tested (n =11), a change to classic utility would tend against the study conclusion in 12 articles (31%). CONCLUSIONS: More than a third of published CUA studies could change if pediatric utilities obtained by recommended, classic methods were used. One-way SAs on utilities are often not presented, making comparison between studies challenging.
引用
下载
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [1] IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)
    Zoratti, M.
    Chan, K.
    Levine, O.
    Krahn, M.
    Husereau, D.
    Clifford, T.
    Schunemann, H.
    Guyatt, G.
    Xie, F.
    VALUE IN HEALTH, 2020, 23 : S286 - S287
  • [2] Trends in the measurement of health utilities in published cost-utility analyses
    Brauer, Carmen A.
    Rosen, Allison B.
    Greenberg, Dan
    Neumann, Peter J.
    VALUE IN HEALTH, 2006, 9 (04) : 213 - 218
  • [3] Update on utilities and cost-utility analyses
    Hollands, Hussein
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2006, 17 (03) : 223 - 227
  • [4] Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease
    Zhou, Ting
    Chen, Zhiyuan
    Li, Hongchao
    Xie, Feng
    MEDICAL DECISION MAKING, 2021, 41 (06) : 685 - 692
  • [5] Are published cost-utility analyses improving?
    Neumann, PJ
    Olchanski, NV
    Rosen, AB
    Greenberg, D
    Chapman, R
    Stone, PW
    Nadai, J
    VALUE IN HEALTH, 2003, 6 (03) : 297 - 297
  • [6] The QALY model: Utilities for cost-utility analysis in health care
    Fryback, DG
    DECISION SCIENCE AND TECHNOLOGY: REFLECTIONS ON THE CONTRIBUTIONS OF WARD EDWARDS, 1999, : 331 - 351
  • [7] Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010
    Wisloff, Torbjorn
    Hagen, Gunhild
    Hamidi, Vida
    Movik, Espen
    Klemp, Marianne
    Olsen, Jan Abel
    PHARMACOECONOMICS, 2014, 32 (04) : 367 - 375
  • [8] Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010
    Torbjørn Wisløff
    Gunhild Hagen
    Vida Hamidi
    Espen Movik
    Marianne Klemp
    Jan Abel Olsen
    PharmacoEconomics, 2014, 32 : 367 - 375
  • [9] Cost-utility studies in upper limb orthopaedic surgery A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE
    Rajan, P. V.
    Qudsi, R. A.
    Dyer, G. S. M.
    Losina, E.
    BONE & JOINT JOURNAL, 2018, 100B (11): : 1416 - 1423
  • [10] Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)
    Michael J. Zoratti
    Kelvin K. W. Chan
    Don Husereau
    Murray Krahn
    Mitchell Levine
    Lehana Thabane
    Feng Xie
    PharmacoEconomics, 2021, 39 : 1075 - 1084